Information Provided By: 
Fly News Breaks for April 21, 2016
STJ
Apr 21, 2016 | 08:06 EDT
Leerink analyst Danielle Antalffy says St. Jude Medical delivered a better-than-expected quarter that suggests that the company may be building sales and EPS growth reacceleration momentum, with the growth trajectory likely to continue improving as the year progresses. The analyst reiterates an Outperform rating and raised her price target on the shares to $80 from $68.
News For STJ From the Last 2 Days
There are no results for your query STJ
